ArticleJournal of gastrointestinal oncology2025
Fluorescence-guided laparoscopic resection of liver segment 4 plus the right anterior ventral section for hepatocellular carcinoma adjacent to the left hepatic pedicle and middle hepatic vein: a case report.
Article in Journal of gastrointestinal oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Seeing the invisible: Three-dimensional liver modeling from simulation to the scalpel.Annals of hepato-biliary-pancreatic surgery · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatectomy is the mainstay of treatment for hepatocellular carcinoma (HCC). Indocyanine green (ICG) fluorescence-guided laparoscopic liver resection is a rapidly developing surgical approach for HCC that has several advantages, including more precise hepatectomy, reduced operative time, less blood loss, and fewer postoperative complications. In this case, a 71-year-old man with chronic hepatitis B and poor medication compliance was diagnosed with HCC. Imaging tests revealed a hepatic mass in segment 4 (S4), closely adjacent to the left hepatic pedicle (LP) and middle hepatic vein (MHV), and with severe liver cirrhosis. The patient underwent ICG fluorescence-guided laparoscopic resection of S4 plus the right anterior ventral section which was also defined as ventral section of segment 5 (S5v) plus segment 8 (S8v). The use of a three-dimensional (3D) reconstruction model improved our ability to develop an optimal surgical plan, and ICG-negative staining assisted in the successful execution of the procedure along the portal venous and hepatic venous territories. The patient, who had enough future liver remnant (FLR), successfully returned to normal life under the guidance of fast-track surgery, and there was no tumor recurrence in the 10-month follow-up period. Combining 3D reconstruction plus ICG fluorescence-guided laparoscopic hepatectomy can help achieve a successful resection of a tumor located in a difficult location for HCC patients presenting with liver cirrhosis. Our case provided clinicians with practical guidance for the management of similar cases, including the technical challenges and the educational value of combining 3D planning and ICG-guided fluorescence in a cirrhotic patient with a tumor located adjacent to major vessels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.